Skip to main content
Jason Mendler, MD, Oncology, Rochester, NY, Strong Memorial Hospital of the University of Rochester

JasonHaroldMendlerMD

Oncology Rochester, NY

Hematologic Oncology

Assistant Professor, Medicine, University of Rochester School of Medicine & Dentistry

Dr. Mendler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Mendler's full profile

Already have an account?

Education & Training

  • Ohio State University Hospital
    Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2009 - 2011
  • University of Rochester
    University of RochesterResidency, Internal Medicine, 2005 - 2008
  • University of Rochester School of Medicine and Dentistry
    University of Rochester School of Medicine and DentistryClass of 2005

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2007 - 2025
  • OH State Medical License
    OH State Medical License 2009 - 2012
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Preliminary Results from a Phase II Study of the Combination of Pevonedistat and Azacitidine in the Treatment of MDS and MDS/MPN after Failure of DNA Methyltransferase...
    Jason H. Mendler, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Access and Referral Barriers to Autologous and Allogeneic Hematopoietic Cell Transplantation in Adult Patients with Cancer: A Systematic Review with a Specific Focus o... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Qualitative Study of Factors That Influence Treatment Decision-Making Among Community Oncologists and Older Patients with Acute Myeloid Leukemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • As Leukemia Evolves, Stem Cells Hold Keys to Newer Therapies
    As Leukemia Evolves, Stem Cells Hold Keys to Newer TherapiesAugust 29th, 2016

Hospital Affiliations